Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial
Kristian Reich, Jacob P. Thyssen, Andrew Blauvelt, Kilian Eyerich, Weily Soong, Zakiya P. Rice, Hwanhee Hong, Norito Katoh, Fernando Valenzuela, Marco DiBonaventura, Tamara A. Bratt, Fan Zhang, Claire Clibborn, Ricardo Rojo, Hernán Valdez, Urs Kerkmann
Topics & Concepts
DupilumabAtopic dermatitisMedicineDouble blindDermatologyRandomized controlled trialInternal medicineAlternative medicinePlaceboPathologyDermatology and Skin DiseasesPsoriasis: Treatment and PathogenesisDrug-Induced Adverse Reactions